Position in AMGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,235,915
+$105,421 QoQ
Shares Held
3,413
+6.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,549
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. AMGN ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,235,915 | 3,413 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,130,494 | 3,213 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,077,504 | 3,292 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $459,986 | 1,630 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $274,184 | 982 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $699,429 | 2,245 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $320,326 | 1,229 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $440,783 | 1,368 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $504,606 | 1,615 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $393,214 | 1,383 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $259,794 | 902 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $327,349 | 1,218 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $238,893 | 1,076 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $708,569 | 2,931 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $631,911 | 2,406 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $479,651 | 2,128 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $471,758 | 1,939 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $549,898 | 2,274 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $775,471 | 3,447 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $702,595 | 3,304 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $733,200 | 3,008 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $778,277 | 3,128 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $756,206 | 3,289 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $857,281 | 3,373 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $240,577 | 1,020 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $208,811 | 1,030 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||